Pediatrics: Hematological and Oncological System

Pediatrics · Clinical Specialties

How it begins

Pediatric hematology and oncology have their own clinical identity, radically different from that of adults: reference values that vary with age, different tumor biology, extraordinarily greater healing capacity, and long-term consequences of treatment that extend for decades. Understanding these particularities is imperative for the optimal management of pediatric patients.

What it covers

1. · Hematopoiesis Sites in Development
2. · Developmental Hemoglobins
3. · Complete blood count by Age: Critical Normal Variations
4. · Morphological Classification (by MCV)
5. · Physiopathological Classification (by reticulocytes)
6. · Etiology by Age Group
7. · Stages of Iron Depletion
8. · Treatment and Prevention
9. · Hereditary Spherocytosis (HE)
10. · Glucose-6-Phosphate Dehydrogenase (G6PDH) Deficiency
11. · Pyruvate Kinase (PK) Deficiency
12. · Sickle Cell Disease (Sickle Cell Disease)
13. · Chronic Treatment of Sickle Cell Disease
14. · Thalassemias: α and β
15. · Severe Acquired Aplastic Anemia (SAA)
16. · Congenital Bone Marrow Failure Syndromes: Fanconi Anemia
17. · Immune Thrombocytopenic Purpura (ITP)
18. · Neonatal Thrombocytopenia
19. · Hemophilia A (Factor VIII) and Hemophilia B (Factor IX)
20. · Modern Treatment of Hemophilia
21. · Von Willebrand Disease (VWD)
22. · Fundamental Differences: Pediatric vs. Adult Cancer
23. · Biological Classification of ALL
24. · Clinical Presentation and Diagnosis
25. · Risk Stratification and Treatment Scheme
26. · Hodgkin lymphoma (HL)
27. · Pediatric Non-Hodgkin's Lymphoma (NHL)